EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Cost-effectiveness of clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review

Saba Abidi, Shridhar Dwivedi, Vinod Sharma, Anoop Kumar, Sushama Talegaonkar

Pharmacoeconomics and Policy · 2026-03 · 2 (1) · 4-11

DOI: 10.1016/j.pharp.2026.03.002 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Pharmacoeconomics and Policy, 2026-03. Verfasst von Saba Abidi und 4 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Abidi, S., Dwivedi, S., Sharma, V., Kumar, A., & Talegaonkar, S. (2026). Cost-effectiveness of clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review. Pharmacoeconomics and Policy, 2(1), 4-11. https://doi.org/10.1016/j.pharp.2026.03.002

Vancouver

Abidi S, Dwivedi S, Sharma V, Kumar A, Talegaonkar S. Cost-effectiveness of clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review. Pharmacoeconomics and Policy. 2026;2(1):4-11. doi:10.1016/j.pharp.2026.03.002

BibTeX
@article{Abidi2026,
  author = {Abidi, Saba and Dwivedi, Shridhar and Sharma, Vinod and Kumar, Anoop and Talegaonkar, Sushama},
  title = {Cost-effectiveness of clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review},
  journal = {Pharmacoeconomics and Policy},
  year = {2026},
  volume = {2},
  number = {1},
  pages = {4--11},
  doi = {10.1016/j.pharp.2026.03.002}
}
Kostenlos starten →